These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 32586319)
1. Integrative analyses of gene expression profile reveal potential crucial roles of mitotic cell cycle and microtubule cytoskeleton in pulmonary artery hypertension. Luo J; Li H; Liu Z; Li C; Wang R; Fang J; Lu S; Guo J; Zhu X; Wang X BMC Med Genomics; 2020 Jun; 13(1):86. PubMed ID: 32586319 [TBL] [Abstract][Full Text] [Related]
2. Identification of novel biomarkers involved in pulmonary arterial hypertension based on multiple-microarray analysis. Ma Y; Chen SS; Feng YY; Wang HL Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32886110 [TBL] [Abstract][Full Text] [Related]
3. Identification of TFRC as a biomarker for pulmonary arterial hypertension based on bioinformatics and experimental verification. Yang C; Liu YH; Zheng HK Respir Res; 2024 Aug; 25(1):296. PubMed ID: 39097701 [TBL] [Abstract][Full Text] [Related]
4. Screening of Hub Genes Associated with Pulmonary Arterial Hypertension by Integrated Bioinformatic Analysis. Zeng Y; Li N; Zheng Z; Chen R; Peng M; Liu W; Zhu J; Zeng M; Cheng J; Hong C Biomed Res Int; 2021; 2021():6626094. PubMed ID: 33816621 [TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of the immune cell infiltration characteristics and correlation with crucial diagnostic markers in pulmonary arterial hypertension. Lian G; You J; Lin W; Gao G; Xu C; Wang H; Luo L BMC Pulm Med; 2023 Aug; 23(1):300. PubMed ID: 37582718 [TBL] [Abstract][Full Text] [Related]
6. Integrated bioinformatic analysis reveals the underlying molecular mechanism of and potential drugs for pulmonary arterial hypertension. Dong H; Li X; Cai M; Zhang C; Mao W; Wang Y; Xu Q; Chen M; Wang L; Huang X Aging (Albany NY); 2021 May; 13(10):14234-14257. PubMed ID: 34016786 [TBL] [Abstract][Full Text] [Related]
7. Identification of hub genes based on integrated analysis of single-cell and microarray transcriptome in patients with pulmonary arterial hypertension. Qin Y; Yan G; Qiao Y; Wang D; Tang C BMC Genomics; 2023 Dec; 24(1):788. PubMed ID: 38110868 [TBL] [Abstract][Full Text] [Related]
8. Identification of Differentially Expressed Genes Associated with Idiopathic Pulmonary Arterial Hypertension by Integrated Bioinformatics Approaches. Zhao E; Xie H; Zhang Y J Comput Biol; 2021 Jan; 28(1):79-88. PubMed ID: 32493063 [TBL] [Abstract][Full Text] [Related]
9. Identification of Signal Pathways and Hub Genes of Pulmonary Arterial Hypertension by Bioinformatic Analysis. Wei RQ; Zhang WM; Liang Z; Piao C; Zhu G Can Respir J; 2022; 2022():1394088. PubMed ID: 36072642 [TBL] [Abstract][Full Text] [Related]
10. Screening of key biomarkers and immune infiltration in Pulmonary Arterial Hypertension via integrated bioinformatics analysis. Zeng Y; Li N; Zheng Z; Chen R; Liu W; Cheng J; Zhu J; Zeng M; Peng M; Hong C Bioengineered; 2021 Dec; 12(1):2576-2591. PubMed ID: 34233597 [TBL] [Abstract][Full Text] [Related]
11. Bioinformatic exploration of the immune related molecular mechanism underlying pulmonary arterial hypertension. Huang R; Zheng X; Wang J Bioengineered; 2021 Dec; 12(1):3137-3147. PubMed ID: 34252346 [TBL] [Abstract][Full Text] [Related]
12. The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis. Wu W; Chen A; Lin S; Wang Q; Lian G; Luo L; Xie L BMC Pulm Med; 2022 Dec; 22(1):474. PubMed ID: 36514015 [TBL] [Abstract][Full Text] [Related]
13. Screening and Identification of Therapeutic Targets for Pulmonary Arterial Hypertension Through Microarray Technology. Li Q; Meng L; Liu D Front Genet; 2020; 11():782. PubMed ID: 32849793 [TBL] [Abstract][Full Text] [Related]
14. Identification of differentially expressed ER stress-related genes and their association with pulmonary arterial hypertension. Yang Q; Lai B; Xie H; Deng M; Li J; Yang Y; Wan J; Liao B; Liu F Respir Res; 2024 May; 25(1):220. PubMed ID: 38789967 [TBL] [Abstract][Full Text] [Related]
15. Bioinformatic analysis and validation of microRNA-508-3p as a protective predictor by targeting NR4A3/MEK axis in pulmonary arterial hypertension. Ma Y; Chen SS; Jiang F; Ma RY; Wang HL J Cell Mol Med; 2021 Jun; 25(11):5202-5219. PubMed ID: 33942991 [TBL] [Abstract][Full Text] [Related]
16. Single-cell transcriptomic profile of human pulmonary artery endothelial cells in health and pulmonary arterial hypertension. Asosingh K; Comhair S; Mavrakis L; Xu W; Horton D; Taylor I; Tkachenko S; Hu B; Erzurum S Sci Rep; 2021 Jul; 11(1):14714. PubMed ID: 34282213 [TBL] [Abstract][Full Text] [Related]
17. Exploration of the Shared Gene Signatures and Molecular Mechanisms Between Systemic Lupus Erythematosus and Pulmonary Arterial Hypertension: Evidence From Transcriptome Data. Yao M; Zhang C; Gao C; Wang Q; Dai M; Yue R; Sun W; Liang W; Zheng Z Front Immunol; 2021; 12():658341. PubMed ID: 34335565 [TBL] [Abstract][Full Text] [Related]
18. Identifying Potential Mitochondrial Proteome Signatures Associated with the Pathogenesis of Pulmonary Arterial Hypertension in the Rat Model. Wang J; Uddin MN; Li Q; Aierken A; Li MY; Wang R; Yan QZ; Adi D; Gai MT; Wu Y Oxid Med Cell Longev; 2022; 2022():8401924. PubMed ID: 35237384 [TBL] [Abstract][Full Text] [Related]
19. Revealing the pathogenic changes of PAH based on multiomics characteristics. Zhang L; Chen S; Zeng X; Lin D; Li Y; Gui L; Lin MJ J Transl Med; 2019 Jul; 17(1):231. PubMed ID: 31331330 [TBL] [Abstract][Full Text] [Related]
20. Identification of Gong Q; Hu Z; Jin Q; Yan Y; Liu Y; He J; Zhuang L; Wang H Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]